Results 141 to 150 of about 25,852 (233)

Association of P2Y12 G52T genetic polymorphism with recurrent thromboembolic events in stroke and myocardial infarction patients on clopidogrel therapy: a prospective observational study. [PDF]

open access: yesSci Rep
Baiju A   +17 more
europepmc   +1 more source

Clopidogrel vs. Aspirin in Double Antithrombotic Therapy for Patients on Oral Anticoagulation Undergoing Coronary Stenting. [PDF]

open access: yesJ Cardiovasc Dev Dis
Pompei G   +7 more
europepmc   +1 more source

Personalized P2Y12 Inhibitor Treatment

open access: yesJACC: Cardiovascular Interventions, 2020
Jurriën M. ten Berg, Paul W.A. Janssen
openaire   +1 more source

Patterns of antithrombotic treatment after left atrial appendage occlusion. [PDF]

open access: yesHeart Rhythm
Liu X   +5 more
europepmc   +1 more source

P2Y12 Inhibitor–Based Monotherapy

open access: yesJournal of the American College of Cardiology, 2020
Rahul Choudhary, Surender Deora
openaire   +1 more source

Early aspirin withdrawal versus dual antiplatelet therapy in high-risk patients after percutaneous coronary intervention: Meta-analysis of randomized trials. [PDF]

open access: yesPLoS Med
Navarese EP   +12 more
europepmc   +1 more source

The efficacy and safety of ticagrelor and prasugrel versus clopidogrel in post-PCI dual antiplatelet therapy in chronic coronary syndrome: a systematic review and meta-analysis. [PDF]

open access: yesBMC Cardiovasc Disord
Mirhosseini SA   +12 more
europepmc   +1 more source

Therapeutic Window of P2Y12 Inhibition

open access: yesJACC: Cardiovascular Interventions, 2019
Iñigo Lozano   +4 more
openaire   +1 more source

2025 Acute Coronary Syndrome Guideline: Missing the Boat on <i>CYP2C19</i> Genotyping. [PDF]

open access: yesJ Am Heart Assoc
Cavallari LH   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy